Yield10 Bioscience, Inc.
YTENQ
$0.015
$0.000.00%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 50.00% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 50.00% | -- | |||
| Cost of Revenue | 11.71% | -30.31% | |||
| Gross Profit | -0.94% | 45.61% | |||
| SG&A Expenses | 45.85% | 6.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.32% | -15.61% | |||
| Operating Income | -31.27% | 24.85% | |||
| Income Before Tax | -30.99% | 24.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.99% | 24.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.99% | 24.31% | |||
| EBIT | -31.27% | 24.85% | |||
| EBITDA | -32.39% | 25.20% | |||
| EPS Basic | -5.72% | 27.14% | |||
| Normalized Basic EPS | -5.72% | 27.13% | |||
| EPS Diluted | -5.66% | 27.09% | |||
| Normalized Diluted EPS | -5.72% | 27.13% | |||
| Average Basic Shares Outstanding | 23.90% | 3.87% | |||
| Average Diluted Shares Outstanding | 23.90% | 3.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
